Publication date: 20 January 2017
Source:Vaccine, Volume 35, Supplement 1
Author(s): Line Matthiessen, Hannu Lång, Maria Klimathianaki, Finnian Hanrahan, Barbara Kerstiëns, Alessandra Martini, Ruxandra Draghia-Akli
Immunisation efforts save millions of lives every year, but vaccines hold the potential to deliver even greater health benefits for mankind. Vaccine research and development is highly complex, and it requires concerted public funding efforts to support. In this paper we discuss EU funding priorities and the resulting recent advancements in European vaccine research, and we lay out the EU strategy for aiding promising vaccine candidates to successfully reach the market.
http://ift.tt/2jQnkCy
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Σάββατο 14 Ιανουαρίου 2017
European strategy for vaccine development against infectious diseases
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου